TGF-beta signaling in renal disease
- PMID: 12239251
- DOI: 10.1097/01.asn.0000033611.79556.ae
TGF-beta signaling in renal disease
Abstract
Since discovery over a decade ago of a role for the cytokine TGF-beta as key mediator of glomerular and tubulointerstitial pathobiology in chronic kidney diseases, studies of TGF-beta signaling in the kidney have focused on the molecular biology of fibrogenesis. In recent years, glomerular and tubular epithelial cell apoptosis and cellular transdifferentiation have been proposed as putative primary pathomechanisms that may underlie progression of renal disease. This review describes evidence in support of nonlinear models and functional roles of TGF-beta signaling in mediating apoptosis and epithelial-to-mesenchymal transdifferentiation (EMT) in chronic progressive renal disease. Emphasis is placed on cell context-dependent models of TGF-beta signaling providing a conceptual framework to consolidate seemingly distinct pathomechanisms of progression of glomerular and tubulointerstitial disease.
Similar articles
-
TGF-beta in renal injury and disease.Semin Nephrol. 2007 May;27(3):309-20. doi: 10.1016/j.semnephrol.2007.02.009. Semin Nephrol. 2007. PMID: 17533008 Review.
-
An integrative view on the role of TGF-beta in the progressive tubular deletion associated with chronic kidney disease.Kidney Int. 2010 Jun;77(11):950-5. doi: 10.1038/ki.2010.88. Epub 2010 Mar 24. Kidney Int. 2010. PMID: 20336053 Review.
-
Transforming growth factor-β and the progression of renal disease.Nephrol Dial Transplant. 2014 Feb;29 Suppl 1:i37-i45. doi: 10.1093/ndt/gft267. Epub 2013 Sep 12. Nephrol Dial Transplant. 2014. PMID: 24030832 Review.
-
Arkadia-Smad7-mediated positive regulation of TGF-beta signaling in a rat model of tubulointerstitial fibrosis.Am J Nephrol. 2007;27(2):176-83. doi: 10.1159/000100518. Epub 2007 Mar 7. Am J Nephrol. 2007. PMID: 17347560
-
A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.J Am Soc Nephrol. 2005 Jan;16(1):68-78. doi: 10.1681/ASN.2003090795. Epub 2004 Nov 10. J Am Soc Nephrol. 2005. PMID: 15537870
Cited by
-
Kindlin-2 mediates activation of TGF-β/Smad signaling and renal fibrosis.J Am Soc Nephrol. 2013 Sep;24(9):1387-98. doi: 10.1681/ASN.2012101041. Epub 2013 May 30. J Am Soc Nephrol. 2013. PMID: 23723426 Free PMC article.
-
Involvement of TGF-β and Autophagy Pathways in Pathogenesis of Diabetes: A Comprehensive Review on Biological and Pharmacological Insights.Front Pharmacol. 2020 Sep 15;11:498758. doi: 10.3389/fphar.2020.498758. eCollection 2020. Front Pharmacol. 2020. PMID: 33041786 Free PMC article. Review.
-
SIRT1 and Kidney Function.Kidney Dis (Basel). 2016 Mar;1(4):258-65. doi: 10.1159/000440967. Epub 2015 Oct 13. Kidney Dis (Basel). 2016. PMID: 27536685 Free PMC article. Review.
-
Newly designed Protein Transduction Domain (PTD)-mediated BMP-7 is a potential therapeutic for peritoneal fibrosis.J Cell Mol Med. 2020 Nov;24(22):13507-13522. doi: 10.1111/jcmm.15992. Epub 2020 Oct 20. J Cell Mol Med. 2020. PMID: 33079436 Free PMC article.
-
Heterozygous knockout of transforming growth factor-β1 protects Dahl S rats against high salt-induced renal injury.Physiol Genomics. 2013 Feb 4;45(3):110-8. doi: 10.1152/physiolgenomics.00119.2012. Epub 2012 Dec 18. Physiol Genomics. 2013. PMID: 23249995 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical